IQ-AI Limited Total Voting Rights (5389E)
February 28 2020 - 8:42AM
UK Regulatory
TIDMIQAI
RNS Number : 5389E
IQ-AI Limited
28 February 2020
IQ-AI Ltd
("IQ-AI" or the "Company")
Total Voting Rights
In accordance with the Financial Conduct Authority's Disclosure
and Transparency Rules, the Company hereby announces that it has
145,955,982 ordinary shares of GBP0.01 in issue, each share
carrying the right to one vote. The Company does not hold any
ordinary shares in treasury.
The above figure of 145,955,982 ordinary shares may be used by
shareholders in the Company as the denominator for the calculations
by which they will determine if they are required to notify their
interest in, or a change to their interest in, the share capital of
the Company under the Financial Conduct Authority's Disclosure and
Transparency Rules.
The Directors of the issuer accept responsibility for the
contents of this announcement.
--ENDS-
For further information, please contact:
IQ-AI Limited
Trevor Brown/Vinod Kaushal/Qu Li
Tel: 020 7469 0930
----------------------------------------------------------
Peterhouse Capital Limited (Financial Adviser and Broker)
Lucy Williams/Heena Karani
Tel: 020 7220 9797
----------------------------------------------------------
About IQ-AI Ltd
IQ-AI, Ltd, the parent company of StoneChecker(R) and Imaging
Biometrics(R), is focused on advanced and state of the art medical
software and services. Imaging Biometrics develops and provides
visualization and analytical solutions that enable clinicians to
better diagnose and treat diseases with greater confidence. Through
close collaboration with researchers and clinicians, sophisticated
advancements are translated into platform-independent software
plug-ins which can extend the base functionality of workstations,
imaging systems, PACS, or medical viewers. By design, IB's advanced
visualization software seamlessly integrates into routine
workflows. Please visit www.imagingbiometrics.com for further
information.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
TVRKKFBNNBKDCBB
(END) Dow Jones Newswires
February 28, 2020 08:42 ET (13:42 GMT)
Iq-ai (LSE:IQAI)
Historical Stock Chart
From Apr 2024 to May 2024
Iq-ai (LSE:IQAI)
Historical Stock Chart
From May 2023 to May 2024